Standardization, analytical validation, and quality control of intermediate endpoint biomarkers
- 1 April 2001
- Vol. 57 (4), 164-170
- https://doi.org/10.1016/s0090-4295(00)00965-1
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancerUrology, 1999
- Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomyUrology, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigenCancer, 1998
- Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United StatesUrology, 1998
- Prostate Cancer Incidence and Mortality Rates among White and Black MenEpidemiology, 1997
- Molecular and cellular biology of prostate cancerCancer and Metastasis Reviews, 1997
- Ability to predict biochemical progression using gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nucleiUrology, 1996
- An Algorithm for Predicting Nonorgan Confined Prostate Cancer Using the Results Obtained from Sextant Core Biopsies with Prostate Specific Antigen LevelJournal of Urology, 1996
- The multistep nature of cancerTrends in Genetics, 1993